Dr. Matthew Meyerson is the director of cancer genomics at the Broad Institute of MIT and Harvard, professor of pathology at Dana-Farber Cancer Institute (DFCI) and Harvard Medical School,
director of the Center for Cancer Genome Discovery at Dana-Farber Cancer Institute, and a principal investigator in The Cancer Genome Atlas project (TCGA) of the National Institutes of Health. Currently, his laboratory aims to utilize genomic approaches to elucidate the genetic changes that give rise to cancer and the role of infectious agents in causing diseases with unknown causes.
Dr. Meyerson has received numerous honors for his work, including the Paul Marks Prize in Cancer Research, the Caine Holter Hope Now award from Uniting Against Lung Cancer, the and the AACR Team Science Award. He received his BA, MD, and PhD from Harvard University.